Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

NCT00413322 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumor

Interventions

DRUG: belinostat
DRUG: 5-Fluorouracil (5-FU)

Sponsor

Valerio Therapeutics